Mahler Michelle
Transaction: 07/29/2026
BUY
Change
+18,000
Price
$2.26
Filing
07/30/2026
Type
BUY
Compugen Ltd.
CGEN • Biotechnology
$0.00
— 0.00 (0.00%)
EarningsLatest report: Jun 30, 2026
FAVORABLE PROFILEAttractiveConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Strong business quality with supportive growth and cash-flow evidence. Valuation still matters, but the historical ratio profile is favorable.
Market Cap
$225.04M
Growth
4.8%
Cash Flow
2/5
Trend
Volatile
Evidence
Stable or improving margins · 48.6%Positive revenue growth · 81.8%Positive free cash flow · 0.34Reasonable earnings multiple · 4.04Manageable debt level · 0.03
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 5, 2026, 2:27 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$0.00
Change0.00%
Market Cap$225.04M
52W Range1.30 - 3.24
Beta2.78
Gross Margin87.29%
Oper. Margin43.05%
Profit Margin48.57%
Debt/Eq0.03
Current Ratio6.56
Quick Ratio6.56
Revenue 5Y4.81%
Price$0.00
Change0.00%
Market Cap$225.04M
52W Range1.30 - 3.24
Beta2.78
Gross Margin87.29%
Oper. Margin43.05%
Profit Margin48.57%
Debt/Eq0.03
Current Ratio6.56
Quick Ratio6.56
Revenue 5Y4.81%
Target$5.00
Target Median$5.00
Target Range5.00 - 5.00
Volume585.47K
Avg Volume390.24K
EPS Surprise-0.01
Investment DNA
How strong this company looks for long-term investors
74
out of 100
Business Quality
Margins, moat, returns
90/100
Financial Strength
Debt, cash, stability
76/100
Growth Potential
Revenue and expansion
58/100
Price Attractiveness
Cheap or expensive today
93/100
Why this score▼
Stable or improving margins · 48.6%Positive revenue growth · 81.8%Positive free cash flow · 0.34Reasonable earnings multiple · 4.04Manageable debt level · 0.03Healthy liquidity · 6.56
Analyst view
Analyst sentiment and price target
Analyst sentiment
No vote count available
Bullish
0
Hold
0
Bearish
0
Price Target
2026-08-05
Low
$5.00
Mean
$5.00
Median
$5.00
High
$5.00
Insider Transactions
Recent executive and insider activity
Mahler Michelle
Transaction: 07/29/2026
BUY
Change
+13,500
Price
Not reported
Filing
07/30/2026
Type
BUY
ZWEIFACH SANFORD S
Transaction: 07/29/2026
BUY
Change
+10,000
Price
$2.26
Filing
07/30/2026
Type
BUY
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| Mahler Michelle | BUY | +18,000 | $2.26 | 07/29/2026 | 07/30/2026 |
| Mahler Michelle | BUY | +13,500 | Not reported | 07/29/2026 | 07/30/2026 |
| ZWEIFACH SANFORD S | BUY | +10,000 | $2.26 | 07/29/2026 | 07/30/2026 |
| ZWEIFACH SANFORD S | BUY | +7,500 | Not reported | 07/29/2026 | 07/30/2026 |
| Halevy Gilead | BUY | +10,000 | $2.26 | 07/29/2026 | 07/30/2026 |
| Halevy Gilead | BUY | +7,500 | Not reported | 07/29/2026 | 07/30/2026 |
| Hukkelhoven Mathias | BUY | +10,000 | $2.26 | 07/29/2026 | 07/30/2026 |
| Hukkelhoven Mathias | BUY | +7,500 | Not reported | 07/29/2026 | 07/30/2026 |
| Livnat Savitzky Kinneret | BUY | +10,000 | $2.26 | 07/29/2026 | 07/30/2026 |
| Livnat Savitzky Kinneret | BUY | +7,500 | Not reported | 07/29/2026 | 07/30/2026 |
| Kredo Russo Sharon | BUY | +24,000 | $2.26 | 07/29/2026 | 07/30/2026 |
| Kredo Russo Sharon | BUY | +18,000 | Not reported | 07/29/2026 | 07/30/2026 |
| Ferre Pierre | BUY | +70,000 | $4.00 | 07/29/2026 | 07/30/2026 |
| Perry Eran | BUY | +10,000 | $2.26 | 07/29/2026 | 07/30/2026 |
| Perry Eran | BUY | +7,500 | Not reported | 07/29/2026 | 07/30/2026 |
| Cohen-Dayag Anat | BUY | +100,000 | $2.26 | 07/29/2026 | 07/30/2026 |
| Ophir Eran | BUY | +200,000 | $2.26 | 07/29/2026 | 07/30/2026 |
| Silberman David | BUY | +26,000 | $2.26 | 07/29/2026 | 07/30/2026 |
| Silberman David | BUY | +19,500 | Not reported | 07/29/2026 | 07/30/2026 |
| Levine Zurit | BUY | +24,000 | $2.26 | 07/29/2026 | 07/30/2026 |